Literature DB >> 7555436

Validation of a new measure of diarrhea.

H R Mertz1, C K Beck, W Dixon, M A Esquivel, R D Hays, M F Shapiro.   

Abstract

Adequate measures of diarrheal disease are important to assess severity for clinical use and outcomes research. We developed a questionnaire to assess diarrhea severity and complications, and administered it to 205 HIV positive patients with diarrhea, fever, or weight loss. Noteworthy variations in stool form were reported by individuals and across subjects. Self-reported diarrhea correlated with the occurrence of any stool pictured without form. However, verbal descriptors "loose" and "semiformed" had little value in assessment of diarrheal disease. Both verbal and pictorial stool descriptors correlated well with diarrhea complications (pain, urgency, tenesmus, incontinence, and nocturnal diarrhea). By factor analysis, discomfort and nondiscomfort diarrhea complications loaded on different factors, consistent with clinical experience that discomfort is a distinct problem in diarrheal disease. In summary we have developed an instrument to precisely characterize diarrhea severity that correlates well with clinically important events such as incontinence and abdominal pain.

Entities:  

Mesh:

Year:  1995        PMID: 7555436     DOI: 10.1007/bf02208649

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  4 in total

1.  The Scree Test For The Number Of Factors.

Authors:  R B Cattell
Journal:  Multivariate Behav Res       Date:  1966-04-01       Impact factor: 5.923

2.  Improving task comprehension in the measurement of health state preferences. A trial of informational cartoon figures and a paired-comparison task.

Authors:  D C Hadorn; R D Hays; J Uebersax; T Hauber
Journal:  J Clin Epidemiol       Date:  1992-03       Impact factor: 6.437

3.  Quality of life and health service use among HIV-infected patients with chronic diarrhea.

Authors:  D P Lubeck; C L Bennett; P D Mazonson; S K Fifer; J F Fries
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-05

4.  Colitis.

Authors:  S J Mallett; J E Lennard-Jones; J Bingley; E Gilon
Journal:  Lancet       Date:  1978-09-16       Impact factor: 79.321

  4 in total
  5 in total

1.  Criterion-related validity of a diarrhea questionnaire in HIV-infected patients.

Authors:  Nathan M Thielman; Philip F Rust; Richard L Guerrant
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

2.  How do existing HIV-specific instruments measure up? Evaluating the ability of instruments to describe disability experienced by adults living with HIV.

Authors:  Kelly K O'Brien; Ahmed M Bayoumi; Carol Strike; Nancy L Young; Kenneth King; Aileen M Davis
Journal:  Health Qual Life Outcomes       Date:  2010-08-19       Impact factor: 3.186

3.  An instrument for the assessment of diarrhoeal severity based on a longitudinal community-based study.

Authors:  Gwenyth Lee; Pablo Peñataro Yori; Maribel Paredes Olortegui; Laura E Caulfield; David A Sack; Christa Fischer-Walker; Robert E Black; Margaret Kosek
Journal:  BMJ Open       Date:  2014-06-06       Impact factor: 2.692

4.  Qualitative development of a patient-reported outcome symptom measure in diarrhea-predominant irritable bowel syndrome.

Authors:  P Marquis; K E Lasch; L Delgado-Herrera; S Kothari; A Lembo; C Lademacher; G Spears; A Nishida; Waldman L Tesler; E Piault; K Rosa; B Zeiher
Journal:  Clin Transl Gastroenterol       Date:  2014-06-26       Impact factor: 4.488

5.  A Comparison of Diarrheal Severity Scores in the MAL-ED Multisite Community-Based Cohort Study.

Authors:  Gwenyth O Lee; Stephanie A Richard; Gagandeep Kang; Eric R Houpt; Jessica C Seidman; Laura L Pendergast; Zulfiqar A Bhutta; Tahmeed Ahmed; Estomih R Mduma; Aldo A Lima; Pascal Bessong; Mats Steffi Jennifer; Md Iqbal Hossain; Ram Krishna Chandyo; Emanuel Nyathi; Ila F Lima; John Pascal; Sajid Soofi; Bodhidatta Ladaporn; Richard L Guerrant; Laura E Caulfield; Robert E Black; Margaret N Kosek
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-11       Impact factor: 2.839

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.